We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · April 01, 2015

Combining Mohs Micrographic Surgery With MART-1 Immunostaining Reduces Recurrence Rates of Melanomas

Journal of the American Academy of Dermatology


Additional Info

Journal of the American Academy of Dermatology
Low Recurrence Rates for In Situ and Invasive Melanomas Using Mohs Micrographic Surgery With Melanoma Antigen Recognized by T Cells 1 (MART-1) Immunostaining: Tissue Processing Methodology to Optimize Pathologic Staging and Margin Assessment
J Am Acad Dermatol 2015 Mar 14;[EPub Ahead of Print], JR Etzkorn, JF Sobanko, R Elenitsas, JG Newman, H Goldbach, TM Shin, CJ Miller

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading